QRG CAPITAL MANAGEMENT, INC.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1996454 BERWYN, PA

Position in REGN

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$386,594

-$155,799 QoQ

Shares Held

620

-11.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#875

of 1,322 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $32,600,934 across 24 Biotechnology names. REGN ranks #21 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	21,665	$10,761,655
2	INVA	Innoviva, Inc.	118,767	$2,697,198
3	PTCT	Ptc Therapeutics, Inc.	24,989	$2,038,352
4	GMAB	Genmab A/S	72,643	$1,995,503
5	ARGX	Argenx SE	1,907	$1,769,257
6	RVMD	Revolution Medicines, Inc.	8,083	$1,513,784
7	INCY	Incyte Corp	13,350	$1,513,356
8	MRNA	Moderna, Inc.	15,957	$1,117,468

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$386,594	620	-11.7%	Shares	Sole	2026-07-14
2026-03-31	$542,393	702	-10.5%	Shares	Sole	2026-04-27
2025-12-31	$605,146	784	-3.4%	Shares	Sole	2026-02-02
2025-09-30	$456,563	812	-59.0%	Shares	Sole	2025-10-28
2025-06-30	$1,040,550	1,982	-52.6%	Shares	Sole	2025-07-21
2025-03-31	$2,653,618	4,184	-79.8%	Shares	Sole	2025-04-17
2024-12-31	$14,753,066	20,711	-10.7%	Shares	Sole	2025-02-05
2024-09-30	$24,367,743	23,180	+4.7%	Shares	Sole	2024-10-30
2024-06-30	$23,269,804	22,140	+3.0%	Shares	Sole	2024-07-12
2024-03-31	$20,695,459	21,502	+4.8%	Shares	Sole	2024-05-07
2023-12-31	$18,019,875	20,517	+1.8%	Shares	Sole	2024-02-07
2023-09-30	$16,580,998	20,148	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.